VTI shares myopia clinical trial results for CLs

Visioneering Technologies Inc (VTI) shared findings from the first year of its clinical trial for its NaturalVue multifocal contact lenses for myopia progression control.  

Results from the Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens (Protect) trial were shared at the American Academy of Optometry meeting in November.  

Study results found that children wearing NaturalVue multifocal lenses reported the same high level of satisfaction, with no noticeable compromise in vision or comfort, as children wearing single vision contact lenses. 

Year one treatment outcomes included children experiencing significant reductions in refractive error and axial length progression regardless of pupil size.